Patrick A. Mayes
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cell death mechanisms and regulation 6
- Oncology 17
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 5
- Cancer-related Molecular Pathways 3
- Co-authors
- Axel Hoos (8 shared papers)Wafik S. El‐Deiry (8 shared papers)Kenneth W. Hance (1 shared paper)John M. Maris (6 shared papers)David T. Dicker (7 shared papers)Kageaki Kuribayashi (3 shared papers)Nicolas Skuli (2 shared papers)M. Celeste Simon (2 shared papers)
- Journals
- Cancer Research (8 papers)Blood (4 papers)Cancer Biology & Therapy (3 papers)Science Translational Medicine (2 papers)Molecular Cancer (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Patrick A. Mayes
31 papers receiving 2.6k citations
Patrick A. Mayes's Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 1.1k
- Cancer Research 494
- Hematology 354
- Immunology 535
- Molecular Biology 1.3k
Countries citing papers authored by Patrick A. Mayes
This map shows the geographic impact of Patrick A. Mayes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick A. Mayes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick A. Mayes more than expected).
Fields of papers citing papers by Patrick A. Mayes
This network shows the impact of papers produced by Patrick A. Mayes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick A. Mayes. The network helps show where Patrick A. Mayes may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick A. Mayes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma Hit paper breakdown → | 2014 | 388 |
| 2 | 2015 | 357 | |
| 3 | 2012 | 311 | |
| 4 | 2018 | 288 | |
| 5 | 2013 | 257 | |
| 6 | 2011 | 200 | |
| 7 | 2010 | 136 | |
| 8 | 2016 | 133 | |
| 9 | 2006 | 122 | |
| 10 | 2008 | 93 | |
| 11 | 2015 | 79 | |
| 12 | 2010 | 42 | |
| 13 | 2011 | 36 | |
| 14 | 2018 | 31 | |
| 15 | 2011 | 27 | |
| 16 | 2022 | 24 | |
| 17 | 2008 | 24 | |
| 18 | 2012 | 17 | |
| 19 | 2005 | 16 | |
| 20 | 2019 | 14 |
About Patrick A. Mayes
Patrick A. Mayes is a scholar working on Molecular Biology, Oncology, Cancer Research, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 32 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Cancer, Hypoxia, and Metabolism (8 papers), Cell death mechanisms and regulation (6 papers), Neuroblastoma Research and Treatments (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Multiple Myeloma Research and Treatments (6 papers), CAR-T cell therapy research (5 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (494 citations), Hematology (354 citations), Immunology (535 citations) and Molecular Biology (1.3k citations). Patrick A. Mayes has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Axel Hoos, Wafik S. El‐Deiry, Kenneth W. Hance, John M. Maris, David T. Dicker, Kageaki Kuribayashi, Nicolas Skuli, M. Celeste Simon, Guoliang Qing and Gabriel Krigsfeld. Their work appears in journals such as Cancer Research, Blood, Cancer Biology & Therapy, Science Translational Medicine and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.